What is the best treatment approach for constipation in a 3-month-old infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Constipation in a 3-Month-Old Infant

For a 3-month-old infant with constipation, fruit juices containing sorbitol (prune, pear, or apple juice) are the recommended first-line treatment, along with ensuring adequate hydration through continued breast-feeding on demand or full-strength formula. 1, 2

Initial Assessment Considerations

Before initiating treatment, ensure this is true constipation and not infant dyschezia (normal grunting and straining in infants under 6 months who have not yet learned to coordinate abdominal pressure with pelvic floor relaxation). 3 True constipation at this age warrants careful evaluation, as delayed passage of meconium beyond 48 hours of life or constipation since birth are red flags that may suggest Hirschsprung disease and require referral. 3, 4

Recommended Treatment Approach

First-Line Non-Pharmacological Management

  • Continue breast-feeding on demand or use full-strength formula to maintain proper hydration, as recommended by the CDC. 1

  • Offer sorbitol-containing fruit juices (prune, pear, or apple juice) which help increase stool frequency and water content in infants with constipation. 1, 2 This is the most appropriate dietary intervention for a 3-month-old.

  • Increase fluid intake to ensure adequate hydration. 1, 2

Pharmacological Options for Infants Under 6 Months

  • Lactulose or lactitol-based medications are authorized and effective for infants before 6 months of age. 5 These osmotic laxatives are preferred when dietary measures alone are insufficient.

  • Glycerin suppositories may be used if rectal examination identifies a full rectum or if immediate relief is needed, as they act as a rectal stimulant through mild irritant action and are safe for this age group. 1

Medications to AVOID in This Age Group

  • Polyethylene glycol (PEG) should NOT be used in infants under 6 months of age; it is only recommended for infants 6 months and older. 1, 5

  • Bisacodyl has no safety or efficacy data for use in infants under 6 months and should be avoided. 1

  • Bulk laxatives (such as psyllium) are not recommended for infant constipation. 6

Critical Pitfalls to Avoid

  • Do not delay referral if constipation has been present since birth or if meconium passage was delayed beyond 48 hours, as these suggest possible Hirschsprung disease. 3, 4

  • Do not use stimulant laxatives as first-line therapy in this age group; osmotic agents or dietary modifications are preferred. 6, 1

  • Avoid relying solely on dietary changes if there is evidence of fecal impaction; suppositories may be needed first. 1

  • Do not use enemas in infants with neutropenia, thrombocytopenia, recent surgery, or anal trauma. 6, 1

When to Refer

Refer immediately to pediatric gastroenterology if there are red flags including: delayed meconium passage, constipation since birth, failure to thrive, developmental delays, or lack of response to initial conservative management. 3, 4 At 3 months of age, organic causes must be ruled out more carefully than in older children, as functional constipation typically develops later during weaning or toilet training. 4

References

Guideline

Treatment of Constipation in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment of Constipation in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Chronic constipation in infants and children.

Singapore medical journal, 2020

Research

[Constipation in infants and children: How should it be treated?].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.